CELC
Price
$15.25
Change
-$0.11 (-0.72%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
PLRX
Price
$14.87
Change
+$0.38 (+2.62%)
Updated
Nov 5, 04:00 PM (EDT)
Earnings call today
Ad is loading...

CELC vs PLRX

Header iconCELC vs PLRX Comparison
Open Charts CELC vs PLRXBanner chart's image
Celcuity
Price$15.25
Change-$0.11 (-0.72%)
Volume$9.24K
CapitalizationN/A
Pliant Therapeutics
Price$14.87
Change+$0.38 (+2.62%)
Volume$25K
CapitalizationN/A
View a ticker or compare two or three
CELC vs PLRX Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CELC vs. PLRX commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and PLRX is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (CELC: $15.34 vs. PLRX: $14.50)
Brand notoriety: CELC and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 58% vs. PLRX: 115%
Market capitalization -- CELC: $563.97M vs. PLRX: $905.94M
CELC [@Biotechnology] is valued at $563.97M. PLRX’s [@Biotechnology] market capitalization is $905.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CELC is a better buy in the short-term than PLRX.

Price Growth

CELC (@Biotechnology) experienced а -2.54% price change this week, while PLRX (@Biotechnology) price change was -2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

CELC is expected to report earnings on Mar 20, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($882M) has a higher market cap than CELC($568M). CELC YTD gains are higher at: 5.285 vs. PLRX (-19.934). CELC has higher annual earnings (EBITDA): -76.03M vs. PLRX (-181.41M). PLRX has more cash in the bank: 437M vs. CELC (283M). PLRX has less debt than CELC: PLRX (60.2M) vs CELC (96.5M). CELC (0) and PLRX (0) have equivalent revenues.
CELCPLRXCELC / PLRX
Capitalization568M882M64%
EBITDA-76.03M-181.41M42%
Gain YTD5.285-19.934-27%
P/E RatioN/AN/A-
Revenue00-
Total Cash283M437M65%
Total Debt96.5M60.2M160%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCPLRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCCIX17.01N/A
N/A
JHancock Small Cap Core I
NRREX14.56N/A
N/A
Neuberger Berman Real Estate R6
LCEIX19.71-0.04
-0.20%
Invesco Diversified Dividend Investor
BHCHX20.43-0.07
-0.34%
Baron Health Care Instl
BTEUX11.94-0.07
-0.58%
Baron Technology R6

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with QSI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+2.75%
QSI - CELC
42%
Loosely correlated
-1.35%
INZY - CELC
41%
Loosely correlated
+1.38%
PLRX - CELC
41%
Loosely correlated
-0.14%
SNDX - CELC
40%
Loosely correlated
-0.21%
ALLO - CELC
40%
Loosely correlated
+10.29%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.14%
NTLA - PLRX
54%
Loosely correlated
+2.30%
BEAM - PLRX
52%
Loosely correlated
+6.24%
PRME - PLRX
50%
Loosely correlated
-1.49%
INZY - PLRX
50%
Loosely correlated
+1.38%
ABSI - PLRX
50%
Loosely correlated
+1.91%
More